tiprankstipranks
Trending News
More News >
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market

Puma Biotechnology (PBYI) Income Statement

Compare
655 Followers

Puma Biotechnology Income Statement

Last quarter (Q3 2025), Puma Biotechnology's total revenue was $54.48M, a decrease of -32.36% from the same quarter last year. In Q3, Puma Biotechnology's net income was $8.84M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 230.47M$ 235.64M$ 228.03M$ 253.16M$ 225.11M
Gross Profit
$ 166.06M$ 172.96M$ 172.94M$ 189.45M$ 185.74M
Operating Expenses
$ 135.10M$ 140.31M$ 149.22M$ 188.16M$ 216.14M
Depreciation and Amortization
$ 11.52M$ 11.52M$ 9.84M$ 11.30M$ 10.03M
EBITDA
$ 48.08M$ 47.52M$ 21.89M$ -4.69M$ -35.71M
Operating Income
$ 30.97M$ 32.64M$ 23.72M$ 1.29M$ -30.40M
Other Income/Expenses
$ -6.87M$ -9.97M$ -23.26M$ -30.09M$ -29.39M
Pretax Income
$ 24.10M$ 22.67M$ 457.00K$ -28.80M$ -59.79M
Net Income
$ 30.28M$ 21.59M$ 2.00K$ -29.13M$ -59.99M
Per Share Metrics
Basic EPS
$ 0.62$ 0.46$ 0.02$ -0.72$ -1.52
Diluted EPS
$ 0.62$ 0.45$ 0.02$ -0.72$ -1.52
Weighted Average Shares Outstanding
48.65M 47.13M 44.67M 40.64M 39.58M
Weighted Average Shares Outstanding (Diluted)
49.10M 47.55M 44.93M 40.64M 39.58M
Currency in USD

Puma Biotechnology Earnings and Revenue History